Patents Represented by Attorney Paul B. Savereide, Ph.D.

Find this attorney in the Justia Lawyer Directory

  • Muteins of human epidermal growth factor exhibiting enhanced binding at low PH
    Patent number: 5547935
    Abstract: EGF muteins in which the histidine at position 16 is replaced with a neutral or acidic amino acid exhibit activity at pHs lower than obtainable with wild type EGF.
    Type: Grant
    Filed: August 2, 1994
    Date of Patent: August 20, 1996
    Assignee: Chiron Corporation
    Inventors: Guy T. Mullenbach, Jeffrey M. Blaney, Steven Rosenberg